Application of metabolomics in oral squamous cell carcinoma
Oral Diseases · 2024-09 · 30 (6) · 3719-3731
DOI: 10.1111/odi.14895 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oral Diseases, online erschienen am 20.02.2024. Verfasst von Guanfa Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, China. Hauptthemen laut MEDLINE: Metabolomics, Mouth Neoplasms, Carcinoma, Squamous Cell, Biomarkers, Tumor. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 115 Literaturangaben. Gefördert von: Wellcome Trust, National Natural Science Foundation of China, Key Research and Development Projects of Jiangsu Province.
Abstract (Originalsprache)
Background
Oral squamous cell carcinoma (OSCC) is a prevalent malignancy affecting the head and neck region. The prognosis for OSCC patients remains unfavorable due to the absence of precise and efficient early diagnostic techniques. Metabolomics offers a promising approach for identifying distinct metabolites, thereby facilitating early detection and treatment of OSCC.
Objective
This review aims to provide a comprehensive overview of recent advancements in metabolic marker identification for early OSCC diagnosis. Additionally, the clinical significance and potential applications of metabolic markers for the management of OSCC are discussed.
Results
This review summarizes metabolic changes during the occurrence and development of oral squamous cell carcinoma and reviews prospects for the clinical application of characteristic, differential metabolites in saliva, serum, and OSCC tissue. In this review, the application of metabolomic technology in OSCC research was summarized, and future research directions were proposed.
Conclusion
Metabolomics, detection technology that is the closest to phenotype, can efficiently identify differential metabolites. Combined with statistical data analyses and artificial intelligence technology, it can rapidly screen characteristic biomarkers for early diagnosis, treatment, and prognosis evaluations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
- Department of Burn and Plastic Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
- Department of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, China.
ORCID-Profile: Guanfa Luo, Xihu Yang
Förderung
- Wellcome Trust
- National Natural Science Foundation of China
- Key Research and Development Projects of Jiangsu Province
- Jiangsu graduate research and practice innovation Program
Zitieren
APA
Luo, G., Wang, S., Lu, W., Ju, W., Li, J., Tan, X., Zhao, H., Han, W., & Yang, X. (2024). Application of metabolomics in oral squamous cell carcinoma. Oral Diseases, 30(6), 3719-3731. https://doi.org/10.1111/odi.14895
Vancouver
Luo G, Wang S, Lu W, Ju W, Li J, Tan X, et al. Application of metabolomics in oral squamous cell carcinoma. Oral Diseases. 2024;30(6):3719-3731. doi:10.1111/odi.14895
BibTeX
@article{Luo2024,
author = {Luo, Guanfa and Wang, Shuai and Lu, Wen and Ju, Wei and Li, Jianhong and Tan, Xiao and Zhao, Huiting and Han, Wei and Yang, Xihu},
title = {Application of metabolomics in oral squamous cell carcinoma},
journal = {Oral Diseases},
year = {2024},
volume = {30},
number = {6},
pages = {3719--3731},
doi = {10.1111/odi.14895}
}
EUVIMED